KNSA
Conviction 66HealthcareScan · Thu, Sep 24, 2026Kiniksa Pharmaceuticals International, plc (KNSA) closed at $75.34 (-0.97%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 95, -6.9% from its 52-week high, +79.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KNSA
Insider activity
SEC Form 4 transactions in KNSA
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Quart Barry D Director · Class A Ordinary Share · 2026-08-19 | Gift | 2.6K | — | 2026-08-19 | 2026-08-21 |
Patel Sanj K CHAIRMAN & CEO · Class B Ordinary Shares · 2026-06-01 | Convert | 900K | $0 | 2026-06-01 | 2026-06-02 |
Patel Sanj K CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01 | Convert | 900K | — | 2026-06-01 | 2026-06-02 |
Patel Sanj K CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
McCain Tracey L Director · Share Option · 2026-05-29 | Grant | 12.16K | $0 | 2026-05-29 | 2026-06-02 |
Levy Richard S Director · Restricted Share Units · 2026-05-29 | Exercise | 2.8K | $0 | 2026-05-29 | 2026-06-02 |
Baker Bros. Advisors (GP) LLC Director · Class A Ordinary Shares · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
Cole G Bradley Director · Restricted Share Units · 2026-05-29 | Grant | 2.03K | $0 | 2026-05-29 | 2026-06-02 |
Popovits Kimberly J Director · Share Option · 2026-05-29 | Grant | 12.16K | $0 | 2026-05-29 | 2026-06-02 |
BAKER FELIX Director · Non- Qualified Share Option (right to buy) · 2026-05-29 | Grant | 36.47K | $0 | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in KNSA · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.